<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25387503</article-id>
      <article-id pub-id-type="pmc">4230667</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20143001</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Skin gangrene as an extraintestinal manifestation of inflammatory bowel
disease<xref ref-type="fn" rid="fn01">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Komatsu</surname>
            <given-names>Yumi Cristina</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Capareli</surname>
            <given-names>Gabriela Cunha</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Boin</surname>
            <given-names>Maria Fernanda Feitosa de Camargo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lellis</surname>
            <given-names>Rute</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Freitas</surname>
            <given-names>Tha&#xED;s Helena Proen&#xE7;a</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Simone</surname>
            <given-names>Karine</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <aff id="aff01"><label>1</label> Santa Casa de Miseric&#xF3;rdia de S&#xE3;o Paulo - S&#xE3;o Paulo (SP),
Brazil.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01"><italic>MAILING ADDRESS:</italic> Yumi Cristina Komatsu, Rua Dr
Ces&#xE1;rio Mota Junior, 112. Vila Buarque, 01221-020 - S&#xE3;o Paulo - SP, Brazil. E-mail:
<email>yumi.komatsu@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Nov-Dec</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2014</year>
      </pub-date>
      <volume>89</volume>
      <issue>6</issue>
      <fpage>967</fpage>
      <lpage>969</lpage>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>7</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>10</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Inflammatory bowel diseases can commonly present many cutaneous lesions which can
contribute to the diagnosis of the disease or its activity. The most frequent
cutaneous or mucocutaneous manifestations suggesting ulcerative rectocolitis activity
are erythema nodosum (3-10%), pyoderma gangrenosum (5-12%) and aphthous stomatitis
(4%). Other reactive skin manifestations related to immunological mechanisms
associated with the inflammatory bowel disease are: Sweet's syndrome,
arthritis-dermatitis syndrome associated with inflammatory bowel disease and
leukocytoclastic vasculitis. We describe the case of a young man with diagnosis of
ulcerative rectocolitis, which presented an extensive cutaneous gangrene secondary to
microvascular thrombosis. The case represents a dermatologic rarity and should be
recognized as a cutaneous manifestation related to the hypercoagulability state
observed in the disease's activity.</p>
      </abstract>
      <kwd-group>
        <kwd>Gangrene</kwd>
        <kwd>Infarction</kwd>
        <kwd>Inflammatory bowel diseases</kwd>
        <kwd>Necrosis</kwd>
        <kwd>Skin abnormalities</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Several cutaneous manifestations are described in Inflammatory Bowel Disease (IBD),
which were classified according to their etiopathogeny: 1) specific or granulomatous
cutaneous diseases, whose histopathology is identical to the basic IBD, such as aphthous
stomatitis, perineal fistulas, subcutaneous nodules; 2) reactive cutaneous
manifestations with immunological mechanisms related to the basic disease activity,
among which we highlight erythema nodosum, pyoderma gangrenosum, Sweet's syndrome,
arthritisdermatitis syndrome associated with inflammatory bowel disease, vasculitides;
3) cutaneous dermatoses associated with IBD, such as psoriasis, secondary amyloidosis,
vitiligo, acquired epidermolysis bullosa, which are rare; and 4) cutaneous
manifestations secondary to complications from IBDs or adverse effects from treatment
for IBDs, such as alterations associated with anemia by iron deficiency, and
acrodermatitis enteropathica secondary to zinc deficiency.<sup><xref rid="r01" ref-type="bibr">1</xref></sup> Crohn's disease and ulcerative rectocolitis encompass 90%
of IBDs, with global incidence of 5 to 10 cases per 100,000 inhabitants/year. Ulcerative
rectocolitis (URC) is three times more frequent than Crohn's disease and has greater
incidence of cutaneous manifestations (34%) and of thromboembolic phenomena like
extra-intestinal manifestations.<sup><xref rid="r02" ref-type="bibr">2</xref></sup></p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>29-year-old man, of mixed race, with a history of ulcerative rectocolitis, had used only
sulfasalazine for 3 years, with a history of onset of 2 erythematous areas on the left
flank, measuring about 7 cm, with well-defined limits, initially painful, which had
evolved to fast-progression necrosis 5 days before (<xref ref-type="fig" rid="f01">Figure 1</xref>). One of the lesions presented a peripheral blister (<xref ref-type="fig" rid="f02">Figure 2</xref>). The left breast presented a painful tumor
with hardened consistency for 1 month. He appeared to be in good general condition,
afebrile and with no complaint of abdominal pains. The laboratory tests demonstrated
normocytic normochromic anemia, discreet thrombocytosis (467,000
platelets/mm<sup>3</sup>), ESR 62 mm/1st hour and CRP 4.3 mg/dl, abnormal liver
function (SGOT 83U/L, ALT 91 U/L, albumin 2.8 g/100ml), very high canalicular enzymes
(FA = 1079 U/L, GGT = 665 U/L) and urine 1 with mild proteinuria (0.25mg protein/ml).
The research of cryoglobulins and immune complexes (ELISA) was negative. Platelet
function and prothrombin time were normal. He underwent biopsy of the edge of the skin
lesion from which histopathological examination revealed microvascular thrombosis
without signs of vasculitis (<xref ref-type="fig" rid="f03">Figure 3</xref>).
Mammography of the left breast showed focal asymmetry in the retroareolar region, which
anatomopathological examination revealed only glandular breast tissue without changes
(<xref ref-type="fig" rid="f04">Figure 4</xref>). Under the conditions presented, the
diagnostic hypothesis for cutaneous gangrene associated with possible mastitis was made.
The treatment of this patient included prednisone (1 mg/kg/day) and sulfasalazine, with
good evolution and progressive improvement of skin lesion.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Ulcers with necrotic surface, well-defined and angled limits and erythematous
halo</p>
        </caption>
        <graphic xlink:href="abd-89-06-0967-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Blister in the periphery of cutaneous lesion</p>
        </caption>
        <graphic xlink:href="abd-89-06-0967-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Microvascular thrombosis, without signs of vasculitis</p>
        </caption>
        <graphic xlink:href="abd-89-06-0967-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Focal asymmetry in the retroareolar region of left breast</p>
        </caption>
        <graphic xlink:href="abd-89-06-0967-g04"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Cutaneous manifestations occur in up to 50% of inflammatory bowel disease (IBD) cases
and are frequently associated with a significant increase of morbidity and mortality,
making it necessary to make therapeutic adjustments. Several cutaneous clinical pictures
were described in IBD. In ulcerative rectocolitis (URC), the biggest incident is
pyoderma gangrenosum, whereas in Crohn's disease it is erythema nodosum.<sup><xref rid="r01" ref-type="bibr">1</xref></sup> Other lesions described are: psoriasis,
erythema multiforme and hyperkeratosis, vitiligo, urticaria, pelagra and vesicular
lesions. In the case described, we did not attribute the skin lesion to a proper
vasculitis, but to microvascular thrombosis, an uncommon complication of IBD - URC. It
arises from the hypercoagulability present in the URC.<sup><xref rid="r03" ref-type="bibr">3</xref></sup> The presence of mastitis can also be associated with the
inflammatory disease by the same skin mechanism, however this was not proven in the
specimen from the anatomopathological breast exam. Studies show that this state of
hypercoagulability is associated with deep venous thrombosis in 5% of cases, and there
is increased risk of cerebral venous thrombosis. Such state of hypercoagulability can be
the result of increased levels of coagulation factor V, VIII and fibrinogen, and to a
decline in levels of antithrombin II due to loss of proteins by enteropathy, whereas
circulating cryoglobulins are other potential causes of cutaneous gangrene.<sup><xref rid="r04" ref-type="bibr">4</xref></sup> Furthermore, other studies showed that
the increased platelet count in ulcerative rectocolitis is associated with
thromboembolic disease, as found in this case.<sup><xref rid="r05" ref-type="bibr">5</xref></sup> The cutaneous gangrene is characterized by a clinical picture of
sudden onset of localized pain, erythema, followed by localized necrosis of epidermis,
which may or may not happen concurrently with the intestinal inflammatory phase and with
thrombotic phenomena in other sites. In this case, the patient was not in an active
disease phase; however, the diagnosis was primary sclerosing cholangitis, an auto-immune
disease also associated with rectocolitis.<sup><xref rid="r06" ref-type="bibr">6</xref></sup> The management of extensive cutaneous gangrene can be done with
prednisolone and intravenous heparin. Complications arising from the use of
anticoagulants during colitis activity were not described. Nevertheless, one can choose
to use low molecular weight heparin in cases of significant bleeding. In this case the
cutaneous disease was self-limiting, so an anticoagulant was not needed for resolution
of the clinical picture, only prednisone. Biopsy of the edge of the cutaneous lesion of
this patient demonstrated microvascular thrombosis (anatomopathological diagnosis:
thrombosing vasculopathy), with no evidence of vasculitis; the finding is compatible
with the clinical picture of cutaneous gangrene.</p>
      <p>It is important to suspect cutaneous gangrene when we face uncommon skin lesions that
clinically do not suggest pyoderma gangrenosum, in a patient with rectocolitis. Complete
hemogram and coagulogram must be performed and early anticoagulation with heparin must
be considered, in order to prevent progression of cutaneous infarction.<sup><xref rid="r04" ref-type="bibr">4</xref></sup></p>
      <p>This case represents a dermatological rarity that demonstrates that the extra-intestinal
manifestation of the cutaneous gangrene type must be recognized as another cutaneous
manifestation related to the activity of the URC.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of Interests: none</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>Financial Support: none</p>
      </fn>
      <fn fn-type="other">
        <p>How to cite this article: Komatsu YC, Capareli GC, Boin MFFC, Lellis R, Freitas THP,
Simone K. Skin gangrene as an extraintestinal manifestation of inflammatory bowel
disease. An Bras Dermatol. 2014;89(6):967-9.</p>
      </fn>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p>Work performed at Irmandade da Santa Casa de Miseric&#xF3;rdia de S&#xE3;o Paulo - Hospital
Central - S&#xE3;o Paulo (SP), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Chandra</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shih</surname>
              <given-names>DQ</given-names>
            </name>
          </person-group>
          <article-title>Skin manifestations of inflammatory bowel disease</article-title>
          <source>Front Physiol</source>
          <year>2012</year>
          <volume>3</volume>
          <fpage>13</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">22347192</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di&#xF3;genes</surname>
              <given-names>AHMD</given-names>
            </name>
            <name>
              <surname>Soares</surname>
              <given-names>JTAS</given-names>
            </name>
            <name>
              <surname>Prokopowitsch</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Neto</surname>
              <given-names>EFB</given-names>
            </name>
            <name>
              <surname>Gon&#xE7;alves</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Neto</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Doen&#xE7;a Inflamat&#xF3;ria Intestinal com Gangrena Cut&#xE2;nea
Mimetizando a Poliarterite Nodosa</article-title>
          <source>Rev Bras Reumatol</source>
          <year>2003</year>
          <volume>43</volume>
          <fpage>334</fpage>
          <lpage>336</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stapleton</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Curley</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Simpson</surname>
              <given-names>WA</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous gangrene, secondary to focal thrombosis - important
cutaneous manifestation of ulcerative colitis</article-title>
          <source>Clin Exp Dermatol</source>
          <year>1989</year>
          <volume>14</volume>
          <fpage>387</fpage>
          <lpage>389</lpage>
          <pub-id pub-id-type="pmid">2612046</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Noshirwani</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>An unusual cutaneous manifestation of ulcerative colitis: thrombotic
skin gangrene</article-title>
          <source>Postgrad Med J</source>
          <year>1996</year>
          <volume>72</volume>
          <fpage>623</fpage>
          <lpage>624</lpage>
          <pub-id pub-id-type="pmid">8977949</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Webberley</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Hart</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Melikian</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Thromboembolism in inflammatory bowel disease: role of
platelets</article-title>
          <source>Gut</source>
          <year>1993</year>
          <volume>34</volume>
          <fpage>247</fpage>
          <lpage>251</lpage>
          <pub-id pub-id-type="pmid">8432482</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>Primary sclerosing cholangitis</article-title>
          <source>N Engl J Med</source>
          <year>1995</year>
          <volume>332</volume>
          <fpage>924</fpage>
          <lpage>933</lpage>
          <pub-id pub-id-type="pmid">7877651</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
